The prognostic impact of beta-blocker therapy in patients with left ventricular dysfunction and chronic obstructive pulmonary disease

被引：0
|
作者：
Kleemann, T [1 ]
Kilkowski, A [1 ]
Bangert, M [1 ]
Lindner, K [1 ]
Siegler, K [1 ]
Senges, J [1 ]
Bergmeier, C [1 ]
机构：
[1] Ctr Heart, Dept Cardiol, Ludwigshafen, Germany
来源：
EUROPEAN HEART JOURNAL | 2001年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [21] Left ventricular dysfunction in relation with systemic inflammation in chronic obstructive pulmonary disease patients
    Gulen, Sule Tas
    Eryilmaz, Ufuk
    Yilmaz, Mustafa
    Karadag, Fisun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (03): : 569 - 578
  • [22] Achieving ventricular rate control in patients taking chronic beta-blocker therapy
    Feeney, Megan E.
    Rowe, Sandra L. B.
    Mah, Nathan D.
    Barton, Cassie A.
    Ran, Ran
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (01): : 110 - 113
  • [23] Impact of chronic obstructive pulmonary disease on left ventricular geometry
    Milovancev, A.
    Kojicic, M.
    Puskar, S.
    Milosavljevic, A. Stojsic
    Stefanovic, M.
    Ilic, A.
    Tadic, S.
    Srdanovic, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 99 - 99
  • [24] Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
    Schupp, Tobias
    Ziyadova, Sevil
    Reinhardt, Julius
    Sag, Yusuf Ugur
    von Zworowsky, Max
    Reiser, Linda
    Abumayyaleh, Mohammad
    Weidner, Kathrin
    Saleh, Ahmad
    Mashayekhi, Kambis
    Bertsch, Thomas
    Abba, Mohammed L.
    Akin, Ibrahim
    Behnes, Michael
    HEART AND VESSELS, 2022, 37 (07) : 1213 - 1223
  • [25] Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
    Tobias Schupp
    Sevil Ziyadova
    Julius Reinhardt
    Yusuf Ugur Sag
    Max von Zworowsky
    Linda Reiser
    Mohammad Abumayyaleh
    Kathrin Weidner
    Ahmad Saleh
    Kambis Mashayekhi
    Thomas Bertsch
    Mohammed L. Abba
    Ibrahim Akin
    Michael Behnes
    Heart and Vessels, 2022, 37 : 1213 - 1223
  • [26] Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic reviewti A systematic review of βB in COPD
    Ruzieh, Mohammed
    Baugh, Aaron D.
    Al Jebbawi, Lama
    Edwards, Emily S.
    Jia, Kelly Qi
    Dransfield, Mark T.
    Foy, Andrew J.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (01) : 53 - 61
  • [27] The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
    Kargin, Feyza
    Takir, Huriye Berk
    Salturk, Cuneyt
    Goksenoglu, Nezihe Ciftaslan
    Karabay, Can Yucel
    Mocin, Ozlem Yazicioglu
    Adiguzel, Nalan
    Gungor, Gokay
    Balci, Merih Kalamanoglu
    Yalcinsoy, Murat
    Kargin, Ramazan
    Karakurt, Zuhal
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2014, 9
  • [28] Beta-blocker therapy and ventricular resynchronization
    Chen, Peng-Sheng
    HEART RHYTHM, 2007, 4 (05) : 689 - 689
  • [29] Improvement of cardiac sympathetic nerve activity and ventricular function in patients with left ventricular (LV) systolic dysfunction after beta-blocker therapy
    Fontanella, B.
    Giubbini, R.
    Metra, M.
    Bordonali, T.
    Verzura, G.
    Lombardi, C.
    Bettari, L.
    Bugatti, S.
    Rodella, C.
    Cas, L. Dei
    EUROPEAN HEART JOURNAL, 2010, 31 : 857 - 857
  • [30] Beta-Blocker Therapy Improves Left Ventricular Ejection Fraction in Heart Transplant Recipients with Allograft Dysfunction
    Poglajen, G.
    Sebestjen, Al.
    Okrajsek, R.
    Haddad, F.
    Vrtovec, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S158 - S158
12345